Our Work

Tech Investments | Medicine / Health Investments | Giving Back

Tech Investments


Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
nuzzel_logo_large_with_hedgehog

Nuzzel

Lucideus Tech

Lucideus is a cybersecurity company that offers its customers with consultancy, training, and solutions to counteract cyber-attacks.

We invested in 2016 and have helped build out the tech team…


Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Pingpad

Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

HEALTH / / MEDICINE INVESTMENTS


Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Reveragen

A small clinical-stage bio-tech company developing therapeutics for inflammatory and muscular diseases. Runs under a venture philanthropy model. Their lead compound, Vamorolone is a steroidal-type anti-inflammatory without typical steroid side effects that could have a wide application in many diseases where corticosteroids are used.

GIVING BACK


Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.